We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
-5.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.62B
AUM Growth
-$2.78B
(-33%)
Cap. Flow
-$2.47B
Cap. Flow
% of AUM
-43.88%
Top 10 Holdings %
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$44.1M |
| 2 |
Harmony Biosciences
HRMY
|
+$36.9M |
| 3 |
Travere Therapeutics
TVTX
|
+$33.9M |
| 4 |
MDLN
Medline Inc
MDLN
|
+$22.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$70.6M |
| 2 |
Immunovant
IMVT
|
+$56.5M |
| 3 |
Dentsply Sirona
XRAY
|
+$53.6M |
| 4 |
GE HealthCare
GEHC
|
+$53.1M |
| 5 |
PTC Therapeutics
PTCT
|
+$51.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.27% |
| 2 | Technology | 7.29% |
| 3 | Consumer Discretionary | 4.25% |
| 4 | Communication Services | 1.58% |
| 5 | Consumer Staples | 1.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Otis Worldwide
OTIS
$28.2B
| $272K | ﹤0.01% |
+3,535
| New | +$309K |
|
202
Qiagen
QGEN
$8.35B
| $272K | ﹤0.01% |
+6,792
| New | +$321K |
|
203
Calumet Specialty Products
CLMT
$3.79B
| $263K | ﹤0.01% |
+7,335
| New | +$190K |
|
|
QXO
204
QXO Inc
QXO
$14.1B
| $263K | ﹤0.01% |
+13,544
| New | +$310K |
|
205
Worksport
WKSP
$10.1M
| $263K | ﹤0.01% |
250,195
-715,813
| -74% | -$1.18M |
|
206
Applied Optoelectronics
AAOI
$8.27B
| $261K | ﹤0.01% |
+3,080
| New | +$197K |
|
207
Cleveland-Cliffs
CLF
$5.12B
| $256K | ﹤0.01% |
+30,295
| New | +$347K |
|
208
First Financial Bancorp
FFBC
$3.72B
| $251K | ﹤0.01% |
+9,000
| New | +$251K |
|
209
Howmet Aerospace
HWM
$109B
| $250K | ﹤0.01% |
+1,085
| New | +$253K |
|
210
Radian Group
RDN
$5.17B
| $249K | ﹤0.01% |
+7,523
| New | +$253K |
|
211
Nuwellis
NUWE
$277K
| $248K | ﹤0.01% |
+6,749
| New | +$455K |
|
212
Dillards
DDS
$8.68B
| $244K | ﹤0.01% |
+427
| New | +$266K |
|
213
Iron Mountain
IRM
$37B
| $240K | ﹤0.01% |
+2,351
| New | +$234K |
|
214
Rocket Lab Corp
RKLB
$41.1B
| $229K | ﹤0.01% |
+3,571
| New | +$269K |
|
215
Agree Realty
ADC
$9.68B
| $228K | ﹤0.01% |
3,025
-10,987
| -78% | -$833K |
|
|
FLY
216
Firefly Aerospace
FLY
$3.23B
| $224K | ﹤0.01% |
+7,881
| New | +$192K |
|
217
Morningstar
MORN
$6.53B
| $224K | ﹤0.01% |
+1,327
| New | +$247K |
|
218
Kimberly-Clark
KMB
$36B
| $223K | ﹤0.01% |
+2,310
| New | +$236K |
|
219
Ford
F
$55.7B
| $222K | ﹤0.01% |
+19,253
| New | +$254K |
|
220
Dutch Bros
BROS
$9.09B
| $222K | ﹤0.01% |
+4,378
| New | +$239K |
|
221
Conagra Brands
CAG
$7.01B
| $220K | ﹤0.01% |
+14,010
| New | +$247K |
|
222
Arcadia Biosciences
RKDA
$1.45M
| $220K | ﹤0.01% |
+159,390
| New | +$312K |
|
223
IPG Photonics
IPGP
$4.16B
| $210K | ﹤0.01% |
+1,835
| New | +$199K |
|
224
Commerce Bancshares
CBSH
$8.46B
| $210K | ﹤0.01% |
4,269
-1,438
| -25% | -$74.7K |
|
225
Calidi Biotherapeutics
CLDI
$2.23M
| $210K | ﹤0.01% |
+879,000
| New | +$660K |
|
Similar funds
CRC
RMDI
F
DWM
DCP
EW
AIM
O
Armistice Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Armistice Capital withdrew a net $2.47B in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.
- Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
- Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
- Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
- Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
- Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
- Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
- Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.
Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.